CD163 and non-small cell lung carcinoma: Additionally, spatial transcriptomic data from the STOmics DB database was leveraged to investigate the spatial distribution of MZF1. Notably, a significant spatial overlap was observed between MZF1 and the M2 macrophage markers CD163 and CD68 in NSCLC tumor tissue (Figure 3C).